Julio Cesar Voltarelli 1948-2012
نویسنده
چکیده
DOI: 10.5581/1516-8484.20120060 Graduated from the Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP) (1967-1972), resident in internal medicine and hematology of Hospital das Clínicas da FMRP-USP (1973-74), M.Sc. (1975-1978) and Ph.D. (1978-1981) degrees in internal medicine (hematology and clinical immunology) from FMRP-USP. Post-doctorate at the University of California, San Francisco, USA (1985-86), the Fred Hutchinson Cancer Research Center in Seattle, USA (1987-88) and Scripps Research Institute in San Diego, USA (1999-2000). Julio Cesar Voltarelli was appointed full professor of the Internal Medicine Department at USP-FMRP, and coordinator of both the Immunogenetics Laboratory (HLA) and the Bone Marrow Transplant Unit of Hospital das Clínicas da USP-FMRP. Researcher in the Centro de Terapia Celular (CEPID-FAPESP) and the Instituto Nacional de Ciência e Tecnologia em Células Tronco e Terapia Celular of the Conselho Nacional de Desenvolvimento Científico e Tecnológico (INCTC CNPq) located in the Centro Regional de Hemoterapia of HC-FMRP-USP. Expert in clinical immunology, hematology and transfusion medicine, in particular in hematopoietic stem cell transplantation for autoimmune diseases, and benign and malignant hematologic diseases and diagnosis and treatment of rheumatic diseases.
منابع مشابه
Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke
Cell therapy has been established as an important field of research with considerable progress in the last years. At the same time, the progressive aging of the population has highlighted the importance of discovering therapeutic alternatives for diseases of high incidence and disability, such as stroke. Menstrual blood is a recently discovered source of stem cells with potential relevance for ...
متن کاملRecent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke.
Cerebrovascular diseases are the third leading cause of death and the primary cause of long-term disability in the United States. The only approved therapy for stroke is tPA, strongly limited by the short therapeutic window and hemorrhagic complications, therefore excluding most patients from its benefits. Parkinson's and Huntington's disease are the other two most studied basal ganglia disease...
متن کاملAutologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
Supplementary material http://jama.ama-assn.org/cgi/content/full/297/14/1568/DC1 News Video JAMA Correction Contact me if this article is corrected. Citations Contact me when this article is cited. This article has been cited 57 times. Topic collections Contact me when new articles are published in these topic areas. Immunology, Other Transplantation; Transplantation, Other; Diabetes Mellitus; ...
متن کاملPeripheral Nerve Repair with Cultured Schwann Cells: Getting Closer to the Clinics
Peripheral nerve injuries are a frequent and disabling condition, which affects 13 to 23 per 100.000 persons each year. Severe cases, with structural disruption of the nerve, are associated with poor functional recovery. The experimental treatment using nerve grafts to replace damaged or shortened axons is limited by technical difficulties, invasiveness, and mediocre results. Other therapeutic ...
متن کاملBula de Software: Uma Estrutura Definida para Promover a Melhoria da Transparência em Software
This article presents a novel proposal for software documentation that is founded on package insert (patient information leaflets) for drugs. The objective of our proposal, called Software Bula, is to provide for users and developers software information that are at the same time clean and well structured and organized.
متن کامل